Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutamine Protective Properties in Cardiac Surgery
NCT01478126Phase 3Completed
- Sponsor
- E. Meshalkin National Medical Research Centre
- Start
- Jan 2012
- Primary completion
- Dec 2012
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in coronary artery disease (CAD) comparing Glutamine with Placebo (2 arms). Primary endpoint: Troponin I. Started Jan 2012; status: completed.
02
Drugs
alanyl glutamine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01478126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01478126.